Clinical Trials

NCT03263572 | RECRUITING | PHASE2
90 participants

Blinatumomab, Methotrexate, Cytarabine, and Ponatinib in Treating Patients With Philadelphia Chromosome-Positive, or BCR-ABL Positive, or Relapsed/Refractory, Acute Lymphoblastic Leukemia

Study Type:
INTERVENTIONAL
Last Updated:
2026-05-20
Start Date:
2017-11-29
Completion:
2027-11-30
Conditions
  • Accelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive
  • Acute Lymphoblastic Leukemia
  • BCR-ABL1 Fusion Protein Expression
  • Blast Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive
  • Philadelphia Chromosome Positive
  • Recurrent Acute Lymphoblastic Leukemia
  • Refractory Acute Lymphoblastic Leukemia
  • t(9;22)
Interventions
  • BIOLOGICAL
  • DRUG
No Results Yet
NCT03093909 | RECRUITING | PHASE1
44 participants

Study of Aerosol Gemcitabine in Patients With Solid Tumors and Pulmonary Metastases

Study Type:
INTERVENTIONAL
Last Updated:
2026-05-20
Start Date:
2017-11-22
Completion:
2027-11-30
Conditions
  • Malignant Neoplasm of Bone and Articular Cartilage
  • Malignant Neoplasms of Female Genital Organs
  • Malignant Neoplasms of Independent (Primary) Multiple Sites
  • Malignant Neoplasms of Lip Oral Cavity and Pharynx
  • Malignant Neoplasm of Male Genital Organs
  • Malignant Neoplasms of Mesothelial and Soft Tissue
  • Malignant Neoplasm of Respiratory and Intrathoracic Organ Carcinoma
  • Malignant Neoplasms of Thyroid and Other Endocrine Glands
  • Malignant Neoplasms of Urinary Tract
  • Melanoma and Other Malignant Neoplasms of Skin
Interventions
  • DRUG
No Results Yet
NCT02965716 | ACTIVE_NOT_RECRUITING | PHASE2
43 participants

Talimogene Laherparepvec and Pembrolizumab in Treating Patients With Stage III-IV Melanoma

Study Type:
INTERVENTIONAL
Last Updated:
2026-05-20
Start Date:
2018-06-05
Completion:
2023-06-30
Conditions
  • Advanced Melanoma
  • Recurrent Melanoma
  • Stage III Cutaneous Melanoma AJCC v7
  • Stage IIIA Cutaneous Melanoma AJCC v7
  • Stage IIIB Cutaneous Melanoma AJCC v7
  • Stage IIIC Cutaneous Melanoma AJCC v7
  • Stage IV Cutaneous Melanoma AJCC v6 and v7
  • Unresectable Melanoma
Interventions
  • BIOLOGICAL
NCT02321501 | ACTIVE_NOT_RECRUITING | PHASE1
37 participants

Ceritinib and Everolimus in Treating Patients With Locally Advanced or Metastatic Solid Tumors or Stage IIIB-IV Non-small Cell Lung Cancer

Study Type:
INTERVENTIONAL
Last Updated:
2026-05-20
Start Date:
2016-06-22
Completion:
2026-12-31
Conditions
  • ALK Positive
  • Locally Advanced Malignant Solid Neoplasm
  • Metastatic Malignant Solid Neoplasm
  • ROS1 Gene Rearrangement
  • Stage IIIB Lung Non-Small Cell Cancer AJCC v7
  • Stage IV Lung Non-Small Cell Cancer AJCC v7
Interventions
  • DRUG
  • OTHER
No Results Yet
NCT02271490 | COMPLETED | NA
111 participants

Acrosome Reaction Induction Prior to ICSI

Study Type:
INTERVENTIONAL
Last Updated:
2026-05-20
Start Date:
2014-12-13
Completion:
2015-05-18
Conditions
  • Assisted Reproductive Technique
  • ICSI
  • Acrosome Reaction
  • Pregnancy Outcome
Interventions
  • OTHER
No Results Yet
NCT02115295 | RECRUITING | PHASE2
508 participants

Cladribine, Idarubicin, Cytarabine, and Venetoclax in Treating Patients With Acute Myeloid Leukemia, High-Risk Myelodysplastic Syndrome, or Blastic Phase Chronic Myeloid Leukemia

Study Type:
INTERVENTIONAL
Last Updated:
2026-05-20
Start Date:
2014-05-19
Completion:
2030-05-31
Conditions
  • Acute Biphenotypic Leukemia
  • Acute Myeloid Leukemia
  • Blast Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive
  • Blasts 10 Percent or More of Bone Marrow Nucleated Cells
  • Blasts 10 Percent or More of Peripheral Blood White Cells
  • de Novo Myelodysplastic Syndrome
  • Myelodysplastic Syndrome
  • Previously Treated Myelodysplastic Syndrome
  • Recurrent Acute Myeloid Leukemia
  • Recurrent Chronic Myelogenous Leukemia, BCR-ABL1 Positive
  • Refractory Acute Myeloid Leukemia
  • Refractory Chronic Myelogenous Leukemia, BCR-ABL1 Positive
  • Secondary Acute Myeloid Leukemia
  • Untreated Adult Acute Myeloid Leukemia
Interventions
  • DRUG
  • OTHER
No Results Yet
NCT01962636 | TERMINATED | NA
200 participants

Umbilical Cord Blood Transplantation Using a Myeloablative Preparative Regimen for Hematological Diseases

Study Type:
INTERVENTIONAL
Last Updated:
2026-05-20
Start Date:
2016-12-31
Completion:
2026-05-14
Conditions
  • Acute Myeloid Leukemia (AML)
  • Acute Lymphocytic Leukemia (ALL)
  • Chronic Myelogenous Leukemia
  • Plasma Cell Leukemia
  • Myelofibrosis
  • Myelodysplasia
  • Chronic Lymphocytic Leukemia
  • Small Lymphocytic Lymphoma
  • Marginal Zone B-Cell Lymphoma
  • Follicular Lymphoma
  • Lymphoplasmacytic Lymphoma
  • Mantle-Cell Lymphoma
  • Prolymphocytic Leukemia
  • Diffuse Large B Cell Lymphoma
  • Lymphoblastic Lymphoma
  • Burkitt's Lymphoma
  • Non-Hodgkin Lymphoma
  • Multiple Myeloma
Interventions
  • RADIATION
  • DRUG
  • BIOLOGICAL
No Results Yet
Previous
Sorted by latest updates
Next
Showing 40 trials per page